Preventing Alzheimer's disease : separating fact from fiction (Q34847609)

4 August 2017

1 reference

title

Preventing Alzheimer's disease : separating fact from fiction (English)

1 reference

4 August 2017

0 references

1

Mary Sano

1 reference

4 August 2017

Hillel Grossman

2

1 reference

PubMed ID

18840031

4 August 2017

Kathleen Van Dyk

series ordinal

3

1 reference

4 August 2017

1 January 2008

1 reference

4 August 2017

1 reference

4 August 2017

22

1 reference

4 August 2017

11

1 reference

4 August 2017

887-902

1 reference

https://scigraph.springernature.com/pub.10.2165/00023210-200822110-00001

4 August 2017

0 references

cites work

A double-blind, placebo-controlled trial of diclofenac/misoprostol in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.2165%2F00023210-200822110-00001

Effects of estrogen on cognition, mood, and cerebral blood flow in AD: a controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00023210-200822110-00001

Estrogen for Alzheimer's disease in women: randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00023210-200822110-00001

Statin therapy and risk of dementia in the elderly: a community-based prospective cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00023210-200822110-00001

The impact of the use of statins on the prevalence of dementia and the progression of cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00023210-200822110-00001

Central nervous system effects of HMG CoA reductase inhibitors: lovastatin and pravastatin on sleep and cognitive performance in patients with hypercholesterolemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00023210-200822110-00001

Do cholesterol-lowering agents affect brain activity? A comparison of simvastatin, pravastatin, and placebo in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00023210-200822110-00001

Effects of treatment with simvastatin and pravastatin on cognitive function in patients with hypercholesterolaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00023210-200822110-00001

A new rating scale for Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00023210-200822110-00001

Cross-sectional and longitudinal association between antihypertensive medications and cognitive impairment in an elderly population.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00023210-200822110-00001

Cognitive decline in individuals with high blood pressure: a longitudinal study in the elderly. EVA Study Group. Epidemiology of Vascular Aging.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00023210-200822110-00001

Hypertension is related to cognitive impairment: a 20-year follow-up of 999 men.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00023210-200822110-00001

Is the cognitive function of older patients affected by antihypertensive treatment? Results from 54 months of the Medical Research Council's trial of hypertension in older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00023210-200822110-00001

Controlled trial of N-acetylcysteine for patients with probable Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00023210-200822110-00001

Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00023210-200822110-00001

Benefits of cognitive-motor intervention in MCI and mild to moderate Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00023210-200822110-00001

Midlife blood pressure and dementia: the Honolulu-Asia aging study.

21 January 2018

1 reference

12 December 2020

Effects of lovastatin and pravastatin on cognitive function in military aircrew.

1 reference

12 December 2020

Risk factors for Alzheimer's disease: a prospective analysis from the Canadian Study of Health and Aging.

1 reference

12 December 2020

Use of lipid-lowering drugs in older adults with and without dementia: a community-based epidemiological study

1 reference

12 December 2020

Statins and the risk of dementia

1 reference

12 December 2020

MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high-risk individuals: a randomised placebo-controlled trial

1 reference

12 December 2020

Full reversal of Alzheimer's disease-like phenotype in a mouse model with conditional overexpression of glycogen synthase kinase-3.

1 reference

12 December 2020

Long-term donepezil treatment in 565 patients with Alzheimer's disease (AD2000): randomised double-blind trial.

1 reference

12 December 2020

Thiamine therapy in Alzheimer's disease

1 reference

12 December 2020

Intravenous immunoglobulins containing antibodies against beta-amyloid for the treatment of Alzheimer's disease

1 reference

12 December 2020

The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics

1 reference

12 December 2020

Increased density of cortical apolipoprotein E immunoreactive neurons in rabbit brain after dietary administration of cholesterol

1 reference

12 December 2020

Sodium salicylate and 17beta-estradiol attenuate nuclear transcription factor NF-kappaB translocation in cultured rat astroglial cultures following exposure to amyloid A beta(1-40) and lipopolysaccharides.

1 reference

12 December 2020

The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial

1 reference

12 December 2020

Proof of efficacy of the ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia.

1 reference

12 December 2020

Exercise level and cognitive decline: the MoVIES project.

1 reference

12 December 2020

Tau phosphorylation, tangles, and neurodegeneration: the chicken or the egg?

1 reference

12 December 2020

Lack of apolipoprotein E dramatically reduces amyloid beta-peptide deposition.

1 reference

12 December 2020

Cholesterol modulates alpha-secretase cleavage of amyloid precursor protein

1 reference

12 December 2020

Do statins reduce risk of incident dementia and Alzheimer disease? The Cache County Study.

1 reference

12 December 2020

Untreated blood pressure level is inversely related to cognitive functioning: the Framingham Study.

1 reference

12 December 2020

Subacute meningoencephalitis in a subset of patients with AD after Abeta42 immunization

1 reference

12 December 2020

Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. Alzheimer's Disease Cooperative Study

1 reference

12 December 2020

Dietary intake of antioxidants and risk of Alzheimer disease

1 reference

12 December 2020

A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study.

1 reference

12 December 2020

Dietary intake of antioxidant nutrients and the risk of incident Alzheimer disease in a biracial community study

1 reference

12 December 2020

Effects of Abeta immunization (AN1792) on MRI measures of cerebral volume in Alzheimer disease.

1 reference

12 December 2020

Idebenone treatment fails to slow cognitive decline in Alzheimer's disease

1 reference

12 December 2020

The pharmacology of amyloid precursor protein processing.

1 reference

12 December 2020

Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study

1 reference

12 December 2020

Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial

1 reference

12 December 2020

Estrogens, progestins, menopause and neurodegeneration: basic and clinical studies

1 reference

12 December 2020

Statin use and hippocampal volumes in elderly subjects at risk for Alzheimer's disease: a pilot observational study.

1 reference

12 December 2020

Preservation of cognitive function with antihypertensive medications: a longitudinal analysis of a community-based sample of African Americans

1 reference

12 December 2020

Microtubule-stabilizing agent prevents protein accumulation-induced loss of synaptic markers

1 reference

12 December 2020

Plasma amyloid beta protein 42 in non-demented persons aged 75 years: effects of concomitant medication and medial temporal lobe atrophy

1 reference

12 December 2020

Cdk5 is a key factor in tau aggregation and tangle formation in vivo.

1 reference

12 December 2020

Donepezil, rivastigmine, and vitamin E in Alzheimer disease: a combined P300 event-related potentials/neuropsychologic evaluation over 6 months.

1 reference

12 December 2020

Salvia officinalis extract in the treatment of patients with mild to moderate Alzheimer's disease: a double blind, randomized and placebo-controlled trial

1 reference

12 December 2020

Release of Alzheimer amyloid precursor derivatives stimulated by activation of muscarinic acetylcholine receptors

1 reference

12 December 2020

A Phase II study targeting amyloid-beta with 3APS in mild-to-moderate Alzheimer disease.

1 reference

12 December 2020

Alpha-1-antichymotrypsin promotes beta-sheet amyloid plaque deposition in a transgenic mouse model of Alzheimer's disease.

1 reference

12 December 2020

Treatment with simvastatin in normocholesterolemic patients with Alzheimer's disease: A 26-week randomized, placebo-controlled, double-blind trial

1 reference

12 December 2020

Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20536 people with cerebrovascular disease or other high-risk conditions

1 reference

12 December 2020

A longitudinal study of cardiorespiratory fitness and cognitive function in healthy older adults

1 reference

12 December 2020

Statin Use and the Risk of Incident Dementia

1 reference

12 December 2020

18-Month study of intravenous immunoglobulin for treatment of mild Alzheimer disease.

1 reference

12 December 2020

Serum lipoprotein levels, statin use, and cognitive function in older women

1 reference

12 December 2020

Melissa officinalis extract in the treatment of patients with mild to moderate Alzheimer's disease: a double blind, randomised, placebo controlled trial

1 reference

12 December 2020

Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset.

1 reference

12 December 2020

Effect of baseline cognitive function and antihypertensive treatment on cognitive and cardiovascular outcomes: Study on COgnition and Prognosis in the Elderly (SCOPE).

1 reference

12 December 2020

Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial

1 reference

12 December 2020

Nonlinear relations of blood pressure to cognitive function: the Baltimore Longitudinal Study of Aging.

1 reference

12 December 2020

Ginkgo for elderly people with dementia and age-associated memory impairment: a randomized clinical trial

1 reference

12 December 2020

Statins and cognitive function in the elderly: the Cardiovascular Health Study

1 reference

12 December 2020

Donepezil versus vitamin E in Alzheimer's disease: Part 2: mild versus moderate-severe Alzheimer's disease.

1 reference

12 December 2020

APOE genotype, cholesterol level, lipid-lowering treatment, and dementia: the Three-City Study.

1 reference

12 December 2020

The efficacy of Ginkgo biloba on cognitive function in Alzheimer disease.

1 reference

12 December 2020

Effects of cognitive-communication stimulation for Alzheimer's disease patients treated with donepezil

1 reference

12 December 2020

1 reference

12 December 2020

Cerebrospinal fluid levels of biomarkers and activity of acetylcholinesterase (AChE) and butyrylcholinesterase in AD patients before and after treatment with different AChE inhibitors.

1 reference

12 December 2020

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

1 reference

12 December 2020

The role of blood pressure in cognitive impairment in an elderly population. Osservatorio Geriatrico Campano Group.

1 reference

12 December 2020

Atorvastatin for the treatment of mild to moderate Alzheimer disease: preliminary results.

1 reference

12 December 2020

Relation of Blood Pressure to Cognitive Function in the Elderly

1 reference

12 December 2020

Cognitive activity and cognitive decline in a biracial community population

1 reference

12 December 2020

Leisure activities and the risk of dementia in the elderly

1 reference

12 December 2020

Diet-induced hypercholesterolemia enhances brain A beta accumulation in transgenic mice

1 reference

12 December 2020

Lipid lowering agents are associated with a slower cognitive decline in Alzheimer's disease

1 reference

12 December 2020

Ginkgo for memory enhancement: a randomized controlled trial.

1 reference

12 December 2020

Generation of Alzheimer beta-amyloid protein in the trans-Golgi network in the apparent absence of vesicle formation

1 reference

12 December 2020

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

1 reference

12 December 2020

Disease-modifying therapies for Alzheimer disease: challenges to early intervention

1 reference

12 December 2020

Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors.

1 reference

12 December 2020

Activation of microglia in the brains of humans with heart disease and hypercholesterolemic rabbits.

1 reference

12 December 2020

Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression: a randomized controlled trial

1 reference

12 December 2020

A randomized, double-blind, study of rofecoxib in patients with mild cognitive impairment

1 reference

12 December 2020

Long-term predictors of cognitive outcome in a cohort of older people with hypertension

1 reference

12 December 2020

Cognitive evaluation of disease-modifying efficacy of galantamine and memantine in the APP23 model

1 reference

12 December 2020

Use of lipid-lowering agents, indication bias, and the risk of dementia in community-dwelling elderly people.

1 reference

12 December 2020

Estrogen attenuates nuclear factor-kappa B activation induced by transient cerebral ischemia

1 reference

12 December 2020

Induction of Alzheimer-like beta-amyloid immunoreactivity in the brains of rabbits with dietary cholesterol.

1 reference

12 December 2020

Efficacy and safety of tarenflurbil in mild to moderate Alzheimer's disease: a randomised phase II trial

1 reference

12 December 2020

Tacrine may alter APP-like protein levels in the lumbar CSF of Alzheimer patients

1 reference

12 December 2020

The Ginkgo Evaluation of Memory (GEM) study: design and baseline data of a randomized trial of Ginkgo biloba extract in prevention of dementia.

1 reference

12 December 2020

Antihypertensive drugs and incidence of dementia: the Rotterdam Study

1 reference

12 December 2020

Rofecoxib: no effect on Alzheimer's disease in a 1-year, randomized, blinded, controlled study

1 reference

12 December 2020

Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse

1 reference

12 December 2020

Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial

1 reference

12 December 2020

Clinical effects of Abeta immunization (AN1792) in patients with AD in an interrupted trial.

1 reference

12 December 2020

Chronic lithium treatment decreases tau lesions by promoting ubiquitination in a mouse model of tauopathies.

1 reference

12 December 2020

Brain estrogen deficiency accelerates Abeta plaque formation in an Alzheimer's disease animal model

1 reference

12 December 2020

Is Alzheimer's disease a neurodegenerative or a vascular disorder? Data, dogma, and dialectics

1 reference

12 December 2020

Long-term effects of Abeta42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial

1 reference

12 December 2020

Ginkgo biloba for cognitive impairment and dementia

1 reference

12 December 2020

Inconsistencies in the classification of preventive interventions

1 reference

12 December 2020

An overview of prevention research: issues, answers, and new agendas

1 reference

12 December 2020

Ovarian steroids and the brain: implications for cognition and aging

1 reference

12 December 2020

Vitamin E and donepezil for the treatment of mild cognitive impairment

1 reference

12 December 2020

Neuroinflammatory perspectives on the two faces of Alzheimer's disease

1 reference

12 December 2020

Relation of plasma lipids to Alzheimer disease and vascular dementia

1 reference

12 December 2020

Neuropathology of human Alzheimer disease after immunization with amyloid-beta peptide: a case report.

1 reference

12 December 2020

A comparison of cognitive ability in normotensive and hypertensive 68-year-old men: results from population study "men born in 1914," in Malmö, Sweden.

1 reference

12 December 2020

Association between statin use and Alzheimer's disease

1 reference

12 December 2020

Safety and efficacy of idebenone versus tacrine in patients with Alzheimer's disease: results of a randomized, double-blind, parallel-group multicenter study

1 reference

12 December 2020

Longitudinally measured blood pressure, antihypertensive medication use, and cognitive performance: the Framingham Study

1 reference

12 December 2020

The effects of exercise training on elderly persons with cognitive impairment and dementia: a meta-analysis

1 reference

12 December 2020

Memantine treatment in mild to moderate Alzheimer disease: a 24-week randomized, controlled trial.

1 reference

12 December 2020

Current and remote blood pressure and cognitive decline.

1 reference

12 December 2020

Short-term folate, vitamin B-12 or vitamin B-6 supplementation slightly affects memory performance but not mood in women of various ages

1 reference

12 December 2020

Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease

1 reference

12 December 2020

Memantine inhibits and reverses the Alzheimer type abnormal hyperphosphorylation of tau and associated neurodegeneration

1 reference

12 December 2020

Demonstrating the case that AD is a vascular disease: epidemiologic evidence

1 reference

12 December 2020

Association of incident Alzheimer disease and blood pressure measured from 13 years before to 2 years after diagnosis in a large community study.

1 reference

12 December 2020

10.2165/00023210-200822110-00001

Identifiers

DOI

1 reference

PubMed ID

18840031

Dimensions Publication ID

4 August 2017

0 references

1 reference

PubMed ID

18840031